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Abstract
In oncology clinical trials, progression-free survival (PFS), generally defined as the time from 
randomization until disease progression (PD) or death, has been a key endpoint to support 
licensing approval (e.g. [1]). When PFS is the primary or co-primary endpoint, it is recommended 
to have tumor assessments verified by an independent review committee (IRC) blinded to study 
treatments, especially in open-label studies (see [1]). It is considered reassuring about the lack of 
reader-evaluation bias if treatment effect estimates from the investigators’ and IRCs’ evaluations 
agree. The agreement between these evaluations may vary for subjects with short or long PFS, 
while there exist no such statistical quantities that can completely account for this temporal pattern 
of agreements. Therefore, in this paper, we propose a new method to assess temporal agreement 
between two time-to-event endpoints, while the two event times are assumed to have a positive 
probability of being identical. This method measures agreement in terms of the two event times 
being identical at a given time or both being greater than a given time. Overall scores of 
agreement over a period of time are also proposed. We propose a maximum likelihood estimation 
to infer the proposed agreement measures using empirical data, accounting for different censoring 
mechanisms, including reader's censoring (event from one reader dependently censored by event 
from the other reader). The proposed method is demonstrated to perform well in small-sample via 
extensive simulation studies and is illustrated through a head and neck cancer trial.
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1. Introduction
Progression-free survival (PFS) has been a key endpoint to support licensing approval in 
some cancer settings (e.g. [1]). PFS is generally defined as the time from randomization 
until disease progression (PD) or death. In oncology clinical trials, radiologic tumor 
assessments are usually performed at pre-defined intervals until PD as determined by an 
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investigator. When PFS is the primary or co-primary endpoint, it is recommended to have 
tumor assessments verified by an independent review committee (IRC) blinded to study 
treatments, especially in open-label studies (see [1]). The primary analysis of PFS for these 
studies may be based on the IRC's evaluation and a sensitivity analysis may be performed 
using the investigators’ evaluation, or vice versa. It is generally considered reassuring about 
the lack of reader-evaluation bias if treatment effect estimates from the investigators’ and 
IRC's evaluations agree.
Historically, less attention has been paid to the agreement (or disagreement) between the 
tumor assessments by the investigators and the IRC itself, compared to its impact on the 
treatment effect estimate. The agreement is of interest for several reasons. First, an 
agreement in treatment effect estimates does not necessarily mean the individual time-to-
event times are the same or close. As pointed out in [2], hazard ratio estimates based on the 
investigators’ and IRC's evaluations were highly concordant in their meta-analysis, but there 
existed a marked degree of individual patient discordance in the timing or occurrence of PD. 
In an extreme case, when the PD time by the IRC's evaluation and the investigators’ 
evaluation differ by a constant for all subjects, the treatment effects measured by the hazard 
ratio are identical from both data sources, even though the evaluations of PD times never 
agree. Second, the median PFS time by treatment arm is often of great interest to clinicians. 
In the aforementioned extreme case, the median PFS times differ by the same constant 
between two data sources, in either treatment arm. Last, it is widely recognized that the 
investigators’ evaluation of PD is potentially biased when the patients’ treatment 
assignments are known to the investigators. Although the IRC is blinded to study treatments, 
and hence expected to reduce observation bias in the investigators’ evaluation, results of the 
IRC's review may be subject to a new bias introduced by a special type of informative 
censoring: in many clinical trials, tumor assessments are discontinued when PD is 
determined by investigators, which precludes an IRC evaluation of PD in subsequent 
assessments. The IRC's evaluation of PD can be dependently censored by the investigator's 
evaluation of PD, which results in the IRC's evaluation of PFS be dependently censored if 
death is not further observed for the subject. Hence, informative censoring occurs for the 
IRC's evaluation of PFS endpoint. In this paper, we refer to this type of informative 
censoring as Reader Censoring (RC). Therefore, it is desirable to have a measure that can 
directly quantify the agreement between the IRC's and the investigators’ evaluations, and 
also develop a robust estimator of an agreement measure in the presence of RC.
There are several agreement measures for assessing dependence or agreement for censored 
bivariate time-to-event data in the literature. The rank-based Kendall's coefficient of 
concordance τ (Section 4.2, [3]) is a measure of overall dependence. It is simple and can be 
estimated non-parametrically for censored data, but does not measure the degree of 
agreement at a single time point. In the aforementioned extreme case, the data achieves the 
maximum value of Kendall's τ, even though there is no agreement of PD time at all. Liu et 
al. [4] provided an estimation method of the concordance correlation coefficient for time-to-
event data. It is a correlation type of measure and has the same issue as Kendall's τ. Guo and 
Manatunga [5] proposed a modified weighted kappa coefficient to measure agreement 
between discrete bivariate survival times, but it requires discretization of continuous 
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outcomes. Amit et al. [2] also proposed two discrepancy rates defined as the simple 
proportion of subjects whose PD time is strictly greater by a reader than the other. These 
rates are naïve approaches by definition and do not fully utilize the temporal nature of time-
to-event data. Guo et al. [6] proposed a new agreement measure, which is formulated as the 
chance-corrected concordance between survival processes on the absolute distance scale.
In this paper, we propose a new method to assess temporal agreement between two time-to-
event endpoints, where the two event times are assumed to have a positive probability of 
being identical. This method measures agreement in terms of the two event times being 
identical at a given time or both being greater than a given time. Overall scores of agreement 
over a period of time are also proposed. While the agreement measures are defined based on 
the underlying distributions of the two time-to-event endpoints, the proposed estimation 
method provides unbiased estimates of the proposed agreement measures (at a given time 
and overall) in the presence of RC in the observed data, for example, the IRC's evaluation of 
PFS. Although the focus of this paper is not to assess the impact of this agreement to the 
estimated treatment effect, the proposed measures can be applied to combined treatment 
arms as well as within each treatment arm to help assess the potential bias in estimating the 
treatment effect.
The development of our method is motivated by a small phase 2 head and neck cancer trial. 
A random subset of all randomized subjects is used here for demonstration purpose. Among 
92 subjects followed-up in the trial, the local assessment yields 82 local PFS events while 
the central assessment gives 72 events and the number of agreed events is 35. In this paper, 
we will apply our development method to assess temporal agreement of the PFS between the 
local and central assessments in this trial dataset.
The paper is organized as follows. In Section 2, we present the methodology and notation 
for the underlying two time-to-event distributions. Furthermore, we propose time-varying 
agreement measures to assess the temporal agreement between two time-to-event endpoints. 
In Section 3, we propose a mixture bivariate survival model and, in Section 4, we describe 
an EM algorithm to estimate the agreement measures induced by this model. Section 5 
studies the small-sample performance of the proposed methods through extensive simulation 
studies. A real data example from the aforementioned head and neck cancer study is 
analyzed in Section 6. Finally, we conclude with a discussion in Section 7.
2. Time-Varying Agreement Measures
Let Tc and Tl denote the two time-to-event endpoints under consideration (e.g. PFS per 
central and local assessment). The idea of defining an agreement measure is such that the 
analysis results based on comparing the hazard rates of the two event times should indicate 
similarity when the agreement between the two event times is high. In censored data 
analysis, the estimates of the hazard ratios, for example, fitting the Cox proportional hazards 
model or performing log-rank tests, are fully dependent on the behavior of the subjects at 
risk at each time t. In other words, the analysis relies on sufficient information regarding the 
number of events and the number of subjects at risk at any time t. Therefore, if Tl and Tc 
agree perfectly, we expect (pretending Tl and Tc to be discrete)
Zeng et al. Page 3














This motivates us to define the following two time-varying agreement measures:
The above two quantities can be interpreted in terms of sensitivity and specificity as well. 
Given that the local event has not occurred prior to time t, at time t, Tl either occurs 
(“disease”) or not (“non-disease”). Treating Tc as a diagnostic measure, we then observe that 
pA is the sensitivity measure while nA is the specificity measure in the usual medical 
diagnostic context.
We vary time t from 0 to the maximum follow-up time TE to obtain the curves pA(t) and 
nA(t). For practical purpose, it will be convenient to use a summary quantity of the curves to 
assess an overall agreement between the two types of events. To this end, we define the 
weighted area under these curves, denoted wAUC(pA) and wAUC(nA), respectively, by
where fTl(t) is the probability density function of Tl. The areas wAUC(pA) and wAUC(nA) 
can be used to measure the overall agreement. The measure wAUC(pA) over the entire 
follow-up period of time is actually the agreement probability P(Tc = Tl).
3. Mixture Models for Estimating Time-Varying Agreements
To estimate the time-varying agreement measures pA(t) and nA(t) using censored data, we 
introduce a mixture model for the bivariate distribution of (Tc, Tl). Specifically, we assume 
that there is some positive chance for Tc and Tl to match. We define the agreement 
probability as p = Pr(Tc = Tl) and assume p > 0. Thus, we model the joint distribution by 
considering two different situations: given Tc = Tl, Pr(Tc > t|Tc = Tl) = S(t); while given Tc 
≠=Tl, we assume (Tc, Tl) follows a continuous bivariate distribution with cumulative 
distribution function (CDF) denoted by Q(t, s). Therefore, for any t and s with t ≤ s, we can 
write down the joint distribution for (Tc, Tl) as
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By symmetry, for any t and s,
Another way of understanding this distribution is to introduce a latent Bernoulli variable B = 
I (Tc = Tl). Then, given B = 1, Tc = Tl follows the distribution 1 – S(t) while given B = 0, (Tc, 
Tl) follows the distribution Q(t, s). This latent variable will be useful for developing the EM 
algorithm for empirical estimation later.
With practical sample sizes, estimating S(t) non-parametrically may not be numerically 
stable. On the other hand, estimating Q(t, s) nonparametrically is not feasible if there exists 
RC in the observed data. Therefore, in the following development, we will adopt a general 
class of parametric distributions for the estimation. Specifically, we will use the Weibull 
distribution to model S(t) while assume Q(t, s) to be from a copula distribution (e.g. see [7, 
8]). We take S(t) = exp [–(λ0t)α0], which is the survival function of the Weibull distribution 
Weibull(α0, λ0), with shape parameter λ0 and inverse scale parameter λ0. We assume Q(t, s) 
is from the following copula distribution: the CDFs of the marginal distributions of Tl and Tc 
given Tl ≠ Tc are 1 – exp [–(λlt)αl] and 1 – exp [–(λct)αc], respectively; the joint distribution 
of Tl and Tc is given as
where Φ(·) is the CDF of the univariate standard normal distribution and ρ describes their 
correlation. For this setting, we obtain
where (Z1, Z2) follows the above bivariate normal distribution.
With the above distributions, we can easily calculate the proposed time-varying agreement 
measures as
and
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where fα,λ(t) and Sα,λ(t) are the density and, respectively, the survival functions of the 
Weibull distribution Weibull(α,λ).
As an illustrative example, we use some distribution settings from the simulation section and 
plot the curves of these agreement measures in Figure 1, where we fix ρ = 0.5 while varying 
p = 0, 0.2, 0.4, 0.6, 0.8, 1, or we fix p = 0.5 while varying ρ, ρ = 0, 0.2, 0.4, 0.6, 0.8, while 
all the other parameters are set to the values in Tables 1 & 2. Values for pA and nA at 
selected times are also given in Tables 1 & 2. Furthermore, we plot the weighted area under 
the curves from 0 to TE, where TE varies from 0.5 to 3.0, p = 0.2, 0.4, 0.6, 0.8, and ρ = 0.5, 
in Figure 2. For comparison, we also plot the Kendall's τ values over [0, TE]. Values for 
wAUC(pA) and wAUC(nA) for selected TE's are also given in Table 3. Tables 1 and 2 and 
Figure 1 show that for given TE, pA(t) and nA(t) vary over time. Table 3 and Figure 2 show 
that by varying TE, wAUC(pA) and wAUC(nA) vary as well and become flat after most 
events have occurred.
4. Observed Likelihood and Inference
In general, the observed data from n i.i.d subjects are
(1)
where Cci and Cli are the respective censoring times for Tci and Tli, Δli = I(Tli≤Cli), and Δci = 
I(Tci≤Cci). We can allow the situation when the RC is present, in which case the observed 
data are
(2)
where Cci and Cli are the respective censoring times for Tci and Tli, Δli = I(Tli≤Cli), and Δci = 
I(Tci min(Cci, {(1 – Δli)∞ + ΔliTli}). Here, we use the convention 0 · ∞ = 0.
Assuming that (Cci, Cli) is noninformative for the joint distribution of (Tci, Tli), we can write 
down the observed likelihood function as follows. In the case of data without RC, for a 
given observation (yci, yli,δci,δli), the likelihood contributions from each subject are from one 
of four groups:
(3)
In the case of data with RC, it comes from one of the following four groups:
(4)
It is clear from the above likelihood formulation that no matter if the censoring is RC or 
even partially RC (i.e., only some central events may be censored by local events), we only 
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need the likelihood from the observed local/central events to make inference about the 
agreement measures.
Specifically, we maximize the observed likelihood function where the part concerning the 
joint distribution of (Cc, Cl) can be dropped. The maximization can be carried out via the 
EM algorithm by treating the latent status, Bi = I(Tci = Tli) as missing data. Then the 
complete-data likelihood function for the above expression corresponds to:
(5)
where f(t) is the derivative of –S(t), q(u, v) is ∂2Q(u, v)/∂u∂v, and Qc(t, s) is the probability 
P(Tc > t, Tl > s), which is equal to 1 – Q(t, ∞) – Q(∞, s) + Q(t, s). The complete-data log-
likelihood function becomes
(6)
For the E-step, we calculate the posterior probability of Bi = 1, denoted by pi, given the 
observed data as follows:
(7)
For the M-step, we estimate the parameters in S(t) by maximizing
(8)
and the parameters in Q(u, v) by maximizing
(9)
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We estimate p by . We iterate between the E- and M-steps until convergence. For 
inference, the information is calculated based on the Louis formula [9] and its inverse is 
used as the sample estimate of the asymptotic covariance of the maximum likelihood 
estimators.
5. Simulation Study
We conducted two sets of simulations, one for data with RC and the other for data without 
RC, to evaluate the accuracy of the parameter estimates, their associated variance estimates, 
and the estimates of the agreement measures pA(t) and nA(t) for our proposed method. We 
also evaluated the performance of the true pA, nA, wAUC(pA), and wAUC(n A). In addition, 
we also evaluated the performance of Kendall's τ and its estimate. All computations were 
done in R.
For these sets of simulations, we assume that along the diagonal (i.e., Tc = Tl) (Tc, Tl) is 
parametrically modeled by the Weibull distribution with shape parameter α0 and inverse 
scale parameter λ0, while outside of the diagonal (i.e., Tc ≠ Tl), Tc and Tl marginally follow 
Weibull distributions with parameters αc, λc and, respectively, αl, λl, and their joint 
distribution is modeled by the copula distribution based on the bivariate normal distribution 
with zero mean, unit variances, and correlation parameter ρ, as in the example of Section 3. 
Recall that we denoted the agreement probability, P(Tc = Tl), by p. For a sample size n, we 
generated the simulated data as follows. We generated Bi ∈ {0, 1}, i = 1,...,n, independently 
from Bernoulli(p). The subjects with Bi = 1 have the event times along the diagonal, i.e. Tci 
= Tli, while those with Bi = 0 have the event times outside the diagonal, i.e. Tci ≠ Tli. Given 
Bi = 1, the common event time Tci = Tli is generated as a random sample from a Weibull(α0, 
λ0) distribution, while given Bi = 0, (Tci, Tli) is generated so that (Φ–1(1 – e–(λcTci)
αc), Φ–1(1 
– e–(λlTli)
αl)) is a random sample from the bivariate normal distribution N2(0, Σ), with 
. For the time-to-event without RC scenario, the simulated data (Yci, Yli, Δci, 
Δli) are obtained by censoring Tci and Tli with a single censoring time Ci, i.e. Cci = Cli, and 
an end time TE (maximum follow-up time). That is, Yci = min(Tci, Ci, TE), Yli = min(Tli, Ci, 
TE), Δci = I(Tci ≤ min(Ci, TE)), and Δli = I(Tli ≤ min(Ci, TE)), i = 1, . . . , n. The censoring 
times (Ci's) are independent of the T's and independently distributed from Weibull(αcens, 
λcens), i = 1, . . . , n. For the time-to-event data with RC scenario, in addition to the time-to-
event data without RC case, the central time Tci is further censored by the local time Tli, i = 
1, . . . , n, as presented in Section 4.
For each simulation setting, we considered sample sizes of n = 100 and 200 and varied the 
agreement proportion p from 0.2 to 0.8. Furthermore, we let λ0 = 0.90, α0 = 1.50, λc = 1.35, 
αc = 1.20, λl = 1.40, αl = 1.30, and π = 0.50. For censoring, we set αcens = 1.10, λcens = 0.75, 
and TE = 3.0 resulting in 36.4% to 43.8% censoring rates. The parametric estimation is 
based on the Weibull distribution. In each case, we generated 500 datasets. For each 
simulated dataset, we applied the EM algorithm to obtain the maximum likelihood 
estimators for the model parameters and their standard errors using the Louis formula. 
Additionally, we calculated the agreement measures pA(t) and nA(t), at time points t = 0.5, 
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1.5, and 2.5. The standard errors for the latter quantities were obtained using the delta 
method.
Tables 1 and 2 give the results from the first simulation setting with RC and from the second 
simulation setting without RC, respectively, where column “SD” denotes the empirical 
standard deviations of the obtained estimates, column “SE” is the estimated standard errors 
by the Louis formula (in [9]), and column “CP” is the 95% coverage probability. Both tables 
indicate that the proposed estimation and inference work well in small samples: the biases 
are small, the estimated standard errors agree well with the empirical standard deviations, 
and the coverage probabilities are close to the nominal level. The coverage probabilities of 
the estimated pA(t) or nA(t) tend to be larger for the time point at the tail but are improved 
when increasing the sample size. Additionally, for each agreement probability, p = 0.2, 0.6, 
0.8, we calculated the estimates and biases of the weighted areas under the curves, 
wAUC(pA)(TE) and wAUC(n A)(TE), of pA and nA respectively, and Kendall's coefficient of 
concordance τ(TE) as functions of the maximum follow-up time TE, in the time-to-event 
data with or without RC. The results for maximum follow-up times TE = 0.5, 1.5, 2.5, and 
3.0. are presented in Table 3. These results show that the estimates are quite accurate and 
that wAUC(pA) approximates the true p for large enough TE when most events have 
occurred.
Finally, we conducted some simulations to examine the robustness of the estimated pA or nA 
to the model misspecification. In the simulations, instead of using the copula model for Q, 
we used the following distribution. Assume that Tc is marginally Weibull(αc, λc) distributed 
and Pr(Tl = Tc|Tc = t) = p(t), where p(t), 0 ≤ p(t) ≤ 1, for t ≥ 0, is a given probability 
function. Given Tl ≠ Tc, we assume Tl given Tc = t satisfies Tl = exp(X) where X is normally 
distributed with mean log(t) and variance σ2. We set λC = 1.35, αC = 1.2, p(t)=ae–rt, with a 
= 0.8 and r = 0.4, and σ2 = 0.5. For this setting, the true value of the agreement probability is 
p = 0.620. For this simulation study, we considered the sample size n = 200, and we 
generated 500 datasets. The results are shown in Table 4. The biases of wAUC(pA) and 
wAUC(n A) are still relatively small, even though the actual joint distribution of (Tc, Tl) 
given Tc ≠ Tl is not of copula type. The agreement measure nA seems to be more sensitive to 
this model assumption than pA when t ≥ 1.
6. Head and Neck Cancer Trial
We consider data from a relatively small phase 2 head and neck cancer clinical trial with n = 
92 subjects (a random subset of all randomized subjects for demonstration purpose). The 
PFS times (in days) were recorded from two different sources, an IRC's evaluation (central) 
and the investigators’ evaluation (local). The range of the central PFS times is from 0 to 861 
days and that of the local PFS times is from 0 to 832 days. There are 72 central and 82 local 
events, respectively. For the purpose of analyzing the data, we exclude the subjects with 
zero central time or zero local time or zero both times from the analysis. There are 89 
subjects with nonzero observed times. For the purpose of this analysis, we rescaled the 
times-to-event to years, i.e., we divided the event times (in days) by 365.25. The event times 
are now in the range [0,3], similar to the time range in our simulation studies. The maximum 
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follow-up time is TE = 2:36. A descriptive summary of the data is shown in Table 5. The 
probability of exact agreement of Tc and Tl is at least 30%.
We fit the model described in Section 3. The estimates, standard deviations, and 95% 
confidence intervals for the parameters p, λ0, α0, λc, αc, λl, αl, ρ are shown in Table 6. The 
estimate of the agreement probability p is p̂ = 0:413. The estimates of the agreement 
measures pA(t) and nA(t), together with their 95% pointwise confidence bands, are shown in 
Table 7 and displayed in Figure 3. The weighted area under the estimated curves  and 
 are 0:412 and 0:843. The wAUCs are calculated over the study duration, that is, over 
the time period from 0 to the last event/censoring time, TE = 2.36. Table 7 shows the 
estimated values of wAUC(pA), wAUC(nA), and Kendall's coefficient of concordance τ. The 
statistic τ only reflects the rank correlation between the two outcomes, Tc and Tl, at any 
time, while our measures pA(t) and nA(t) give the exact agreement probabilities at any time 
t. Our measures are more informative than the Kendall's coefficient τ.
The results indicate that both the local and central times agreed well at the beginning and 
end of this study. The relatively higher agreement at the end of the study is mostly due to 
death for subjects without either local or central PD. The local and central diagnosis for the 
non-event cases were similar. The plots in Figure 3 indicate a large variability of the 
agreements over time; thus, it is necessary to account for this temporally variable agreement 
in any further analysis.
7. Discussion
We have proposed a new method to assess agreement between two time-to-event endpoints, 
where the two event times are assumed to have a positive probability of being identical. 
Such an assumption is motivated by type of data we targeted. For example, the head and 
neck cancer trial data show that the probability of exact agreement of the two event times is 
at least 30%. We can view our model as a two-pattern mixture model, with Tc = Tl being one 
pattern. Although, it is not uncommon that the two evaluations are based on measurements 
which are usually performed at predefined time intervals, there might be a large amount of 
variation in the two observed event times, so Tc ≠ Tl, with Tc and Tl continuous random 
variables, is another pattern (see head and neck cancer trial data, Table 5). Other approaches 
may be envisioned for modeling same type of data. For example, one can set up the two 
event times in a discrete failure time setting, by considering a model arising from a single 
copula model, which is then discretized according to the observation windows and estimate 
accordingly. However, such an approach is not the scope of this paper. Nonetheless, it is an 
interesting alternative approach and can be addressed in a separate research.
Our method measures agreement in terms of two event times of being identical at a given 
time point or both being greater than a given time, assuming that the event had not occurred 
prior to the given time. The proposed agreement measures are based on the underlying joint 
distribution of the time-to-event endpoints. We estimate the proposed agreement measures 
using a mixture parametric distribution based on Weibull distributions, which are general 
enough to cover a wide range of applications. However, it is of interest to further relax this 
parametric assumption while consider even more flexible or nonparametric distributions for 
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both S(t) and Q(t, s) in future work. Sieve estimation based on splines may be useful for 
carrying out inference, but will increase the computation complexity. Although our 
agreement measures are defined as the conditional probability of the central event given the 
local event, this definition can be similarly defined as the reverse conditional probability or 
the summation of both conditional probabilities, especially when there is no preference to 
either event.
Our approach is fully likelihood-based and the informative censoring RC is naturally 
accounted for in the likelihood formulation. So, it has no impact on the validity of our 
method. As shown in the simulation study, the relative biases of the proposed agreement 
measures for data without RC and data with RC are very similar. Our method yields robust 
estimators of the agreement measures in the presence of RC. However, if the censoring is 
truly informative (depends on potential outcome value), modelling censoring mechanism is 
necessary to obtain a valid inference.
The proposed method can be directly applied to other commonly used endpoints for 
oncology clinical trials, for example, time-to-progression and disease free survival ([1]), to 
assess their agreement between IRC's and investigators’ evaluation. In addition, by jointly 
modeling the IRC's and investigators’ assessments, the proposed estimation method can 
provide less-biased estimates of the parameters in the assumed underlying distribution than 
those based on IRC's assessment alone. One application is to apply the method within each 
treatment arm and then make inference about treatment effect with the estimated underlying 
distribution. High values (e.g., > 80%) of the measure wAUC(pA) in both treatment and 
control arms provide a high assurance of assessing treatment effects using the investigator's 
evaluations only, which implies investigator's reading data are robust and reliable to 
estimate treatment effects; on the contrast, lower values require the need for the IRC's 
readings in clinical trials. Another application is for event projection. The primary analysis 
in most oncology trials are event driven (i.e., based on planned number of events). When the 
primary analysis is based on IRC's evaluation, event modeling based on the estimated 
underlying distribution of the IRC's data from joint modeling of IRC's and investigator's data 
provide more accurate projection of future events than that from modeling of IRC's data 
alone.
The proposed temporal agreement measurements are potentially useful for future trials when 
central assessment is needed for auditing purposes, since time-to-event outcomes such as 
PFS, are usually subject to measurement error. For example, it was reported that a 
discrepancy in PFS times between local and central assessment could range from 23% to 
36% [10]. Recently, there has been some development to address this discrepancy [10, 11]. 
With the development of our temporal agreement measurements, we will be able to not only 
capture the overall agreement, but also assess the temporal discrepancy between these two 
assessments; therefore, the differences in the analyses based on local and central 
assessments will be quantified more precisely. Furthermore, the proposed temporal 
agreement measurements will also be useful to help design more effective and efficient audit 
strategies. For instance, if the disagreement occurs most often for long survivals, an audit 
should then be applied to those subjects. In future work, we will examine how to incorporate 
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this temporal agreement measure into designing an audit strategy to correct bias due to 
imprecise local assessments.
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Plots of the curves of the agreement measures pA and nA. Top: ρ = 0.5 fixed and p varying, 
p = 0, 0.2, 0.4, 0.6, 0.8, 1; bottom: p = 0.5 fixed and ρ varying, ρ = 0, 0.2, 0.4, 0.6, 0.8; all 
other parameters being set to the values as in Tables 1 & 2, and TE = 3.0.
Zeng et al. Page 13














Plots of the areas, wAUC(pA) and wAUC(nA), under the agreement measure curves pA and 
nA, respectively, and the Kendall's coefficient of concordance τ.
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Plots of the estimated curves of the agreement measures pA and nA, together with the 
pointwise 95% confidence bands, over the study duration for PFS data. The weighted AUCs 
are wAUC(pA) = 0.412 and wAUC(n A) = 0.843.
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Table 3
True values, estimates, and biases of the weighted area under the curve of the agreement measures pA and nA, 
and of Kendall's coefficient of concordance τ, in both data with RC and without RC cases, for maximum 
follow-up times TE = 0.5, 1.5, 2.5, 3.0, agreement probabilities p = 0.2, 0.6, 0.8, sample size n = 200, and all 
the other parameters as in Tables 1 and 2.
p Agreement Measure Maximum Follow-up Time True Value
Data with RC Data without RC
Estimate Bias Estimate Bias
p = 0.2
wAUC(pA)
0.5 0.1224 0.1202 −0.0023 0.1197 −0.0027
1.5 0.1759 0.1814 0.0055 0.1809 0.0050
2.5 0.1955 0.1997 0.0042 0.1992 0.0038
3.0 0.1984 0.2017 0.0034 0.2013 0.0029
wAUC(nA)
0.5 0.8696 0.8695 −0.0001 0.8695 −0.0001
1.5 0.7734 0.7721 −0.0013 0.7720 −0.0013
2.5 0.7602 0.7580 −0.0022 0.7579 −0.0023
3.0 0.7595 0.7570 −0.0025 0.7569 −0.0026
τ 
0.5 0.2602 0.3108 0.0506 0.4237 0.1634
1.5 0.3727 0.3457 −0.0270 0.4530 0.0803
2.5 0.4244 0.3476 −0.0769 0.4536 0.0291
3.0 0.4328 0.3477 −0.0851 0.4536 0.0208
p = 0.6
wAUC(pA)
0.5 0.4557 0.4520 −0.0037 0.4520 −0.0037
1.5 0.5615 0.5599 −0.0016 0.5602 −0.0012
2.5 0.5931 0.5911 −0.0020 0.5917 −0.0014
3.0 0.5975 0.5952 −0.0024 0.5958 −0.0018
wAUC(nA)
0.5 0.9379 0.9376 −0.0003 0.9375 −0.0004
1.5 0.9027 0.9018 −0.0009 0.9021 −0.0006
2.5 0.9009 0.9005 −0.0004 0.9010 9.5e-05
3.0 0.9012 0.9009 −0.0004 0.9014 0.0002
τ 
0.5 0.5597 0.5876 0.0280 0.6532 0.0936
1.5 0.6392 0.6370 −0.0022 0.6925 0.0532
2.5 0.6797 0.6390 −0.0407 0.6934 0.0138
3.0 0.6863 0.6391 −0.0472 0.6934 0.0072
p = 0.8
wAUC(pA)
0.5 0.6906 0.6896 −0.0010 0.6900 −0.0006
1.5 0.7735 0.7719 −0.0015 0.7726 −0.0009
2.5 0.7954 0.7954 −0.0000 0.7959 0.0006
3.0 0.7983 0.7984 9.4e-05 0.7990 0.0007
wAUC(nA)
0.5 0.9695 0.9692 −0.0002 0.9696 9.9e-05
1.5 0.9543 0.9551 0.0008 0.9554 0.0011
2.5 0.9543 0.9564 0.0021 0.9566 0.0023
3.0 0.9546 0.9568 0.0023 0.9570 0.0024
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p Agreement Measure Maximum Follow-up Time True Value
Data with RC Data without RC
Estimate Bias Estimate Bias
τ 
0.5 0.7596 0.7727 0.0131 0.8038 0.0443
1.5 0.8068 0.8103 0.0035 0.8359 0.0291
2.5 0.8315 0.8117 −0.0199 0.8369 0.0054
3.0 0.8356 0.8118 −0.0238 0.8369 0.0014
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Table 4
Summary of simulation results for data from the distribution described at the end of Section 5, for which the 




True Value Estimate Bias Rel. Bias (%) True Value Estimate Bias Rel. Bias (%)
0.50 0.6963 0.7176 0.0213 3.06 0.9763 0.9709 −0.0055 −0.56
1.00 0.6824 0.6727 −0.0098 −1.43 0.9596 0.9338 −0.0258 −2.69
1.50 0.6677 0.6511 −0.0167 −2.50 0.9524 0.9063 −0.0461 −4.84
2.00 0.6550 0.6416 −0.0134 −2.04 0.9499 0.8910 −0.0589 −6.20
2.50 0.6452 0.6379 −0.0073 −1.13 0.9492 0.8842 −0.0650 −6.85
3.00 0.6383 0.6367 −0.0016 −0.25 0.9491 0.8817 −0.0674 −7.10
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Table 5
Head and neck cancer trial data information at times t = 0.5, 1.5, 2.5. (n = 89)
Time
Average percentage of subjects (%)
YC = YL YC < YL YC > YL
0.5 Both Censored 28.09 0.00 1.12
Central Event Only 1.12 11.24 1.12
Local Event Only 6.74 0.00 6.74
Both Events 31.46 12.36 0.00
1.5 Both Censored 4.49 0.00 1.12
Central Event Only 1.12 3.37 1.12
Local Event Only 11.24 0.00 7.87
Both Events 37.08 24.72 7.86
2.5 Both Censored 2.25 0.00 1.12
Central Event Only 1.12 2.25 1.12
Local Event Only 11.24 0.00 4.49
Both Events 39.33 25.84 11.24
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Table 6
Parameter estimates, standard deviations, and 95% confidence intervals of the parameters for the head and 
neck cancer trial data. ( sample size n = 89).
Parameter Estimated Value Standard Deviation (Louis)
95% CI
lower bound upper bound
p 0.413 0.053 0.314 0.520
λ 0 2.209 0.419 1.522 3.205
α 0 0.998 0.129 0.774 1.286
λ C 1.284 0.194 0.955 1.727
α C 1.088 0.140 0.845 1.401
λ L 1.463 0.139 1.215 1.762
α L 1.664 0.192 1.327 2.087
ρ 0.612 0.118 0.330 0.794
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